NCT03283917 2026-02-27Daratumumab, Ixazomib, and Dexamethasone in AL AmyloidosisM.D. Anderson Cancer CenterPhase 1 Active not recruiting21 enrolled
NCT04754945 2026-02-18Isatuximab as Upfront Therapy for the Treatment of High Risk AL AmyloidosisEmory UniversityPhase 1 Active not recruiting11 enrolled